Inner Mongolia Yili Industrial Group has filed a patent for the use of human milk oligosaccharide, specifically fucosyl-based oligosaccharide 2′-FL or 3-FL, in improving the health of the intestinal microenvironment. The oligosaccharide can be added to infant foods, nutritional supplements, and foods for children, adolescents, and adults. The method involves administering the food containing human milk oligosaccharide to a subject to function as prebiotics, lower pH, and reduce branched chain fatty acids in the intestinal system. GlobalData’s report on Inner Mongolia Yili Industrial Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inner Mongolia Yili Industrial Group, Lactobacilli-based drug compositions was a key innovation area identified from patents. Inner Mongolia Yili Industrial Group's grant share as of September 2023 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Improving intestinal health using human milk oligosaccharide in food
A recently filed patent (Publication Number: US20230285431A1) describes a method for improving the health of the intestinal microenvironment. The method involves administering a food containing human milk oligosaccharide to a subject. The human milk oligosaccharide acts as a prebiotic in the intestinal system, which is utilized by the intestinal flora to produce gas. It also helps in lowering the pH to maintain the health of the intestinal microenvironment and reducing branched chain fatty acids.
The patent claims specify different types of human milk oligosaccharides that can be used in the method. These include fucosyl-based oligosaccharides, sialyl-based oligosaccharides, and lacto-N-tetraose. Examples of specific oligosaccharides mentioned are 2'-FL, 3-FL, 3-SL, and 6-SL.
The method can be implemented using various types of food, such as nutritional supplements, infant formula powder, and supplementary food. The patent also provides specific dosage ranges for the human milk oligosaccharides in the food, depending on the type of oligosaccharide and the form of the food (powder or liquid milk).
Additionally, the patent claims that the method can be used to regulate the production of beneficial short chain fatty acids in the intestinal system. These include formic acid, acetic acid, propionic acid, and butyric acid. Specific oligosaccharides, such as 6-SL, are mentioned for regulating the production of butyric acid in the proximal and distal colon.
Overall, this patent describes a method for improving the health of the intestinal microenvironment by administering human milk oligosaccharides. The method has potential applications in various food products and can help regulate the production of beneficial short chain fatty acids.
To know more about GlobalData’s detailed insights on Inner Mongolia Yili Industrial Group, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
